Press Releases
Select a Month...
-
Seattle Children’s Researchers Identify Drug That Could Suppress Intractable Epilepsy
12.3.15
Study shows successful treatment of epilepsy in mouse models within one hour of using drug to target genetic pathway known to cause the condition
-
Seattle Children’s Researchers Discover Method to Prevent Lethal Bone Marrow Transplant Complication
11.30.15
Study in Science Translational Medicine identifies drug target and genetic pathway for graft-versus-host disease, a dangerous and common complication of bone...
-
Lisa Hayward Appointed Senior Vice President, General Counsel for Seattle Children’s
11.3.15
Hayward replaces Jeff Sconyers, who retired earlier this year
-
Seattle Children’s, PATH and the UW School of Dentistry Nominated for $250,000 Award to Fund Research and Development of Lifesaving Device for Infants Who Can’t Nurse
9.17.15
The Neonatal Intuitive Feeding TechnologY (NIFTY™ cup) has the potential to save or improve the lives of millions of infants in low-resource settings who are...
-
Seattle Children’s Research Institute Teams Up With bluebird bio to Pioneer Genome Editing and Gene Therapy Research in Pediatric Diseases
9.10.15
Gene therapy research aims to cure pediatric diseases early in life by targeting and repairing the disease-causing genes in a patient’s own genome
-
Seattle Children’s Opens New Clinic to Increase Access to Specialty Care Services for Families in South Sound
8.18.15
New clinic replaces the Seattle Children’s Federal Way facility, which closed on Aug. 12
-
Seattle Children’s Opens Patient Enrollment for First Tumor Paint Clinical Trial for Children With Brain Cancer
6.4.15
Tumor Paint BLZ-100 aims to improve surgical outcomes by acting as a molecular flashlight that allows surgeons to visibly distinguish tumor cells from healthy...
-
Research Finds Preschoolers Need More Opportunities for Active Play
5.18.15
Children in preschool and daycare settings are only offered 48 of 120 recommended minutes of active play daily, study shows
-
Promising Research Trials Find New Combination of Drugs Treat Underlying Cause of Most Common Form of Cystic Fibrosis
5.17.15
New medication also reduces by 40 percent the number of pulmonary exacerbations, the leading cause of death in cystic fibrosis patients
-
Dr. Sandy Melzer Appointed Seattle Children’s Executive Vice President for Networks, Population Health
5.14.15
New position will focus on strategies to ensure that every child and family has access to the healthcare services they need
